연구동향 분석
박사

Matrix metalloproteinase-2,9 expression in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β = tumor necrosis factor-α와 interleukin-1β가 척추 황색인대 세포의 matrix metalloproteinase-2,9 발현에 미치는 영향

김범준 2015년

논문상세정보
인용/피인용
' Matrix metalloproteinase-2,9 expression in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β = tumor necrosis factor-α와 interleukin-1β가 척추 황색인대 세포의 matrix metalloproteinase-2,9 발현에 미치는 영향' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • elastin degradation
  • gelatin zymography
  • interleukin-1β
  • ligamentum flavum hypertrophy
  • matrix metalloproteinase
  • tumor necrosis factor-α
  • western blot
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
97 0

0.0%

' Matrix metalloproteinase-2,9 expression in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β = tumor necrosis factor-α와 interleukin-1β가 척추 황색인대 세포의 matrix metalloproteinase-2,9 발현에 미치는 영향' 의 참고문헌

  • Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9proteolytically activates TGF-гогС and promotes tumor invasion andangiogenesis. Genes Dev 2000;14:163-76.
  • Yahia L-H, Garzon S, Strykowski H, et al. Ultrastructure of the HumanInterspinous Ligament and Ligamentum Flavum A Preliminary Study.Spine 1990;15:262-8.
  • Woessner JF. Matrix metalloproteinases and their inhibitors in connectivetissue remodeling. FASEB J 1991;5:2145-54.
  • Warner RL, Bhagavathula N, Nerusu KC, et al. Matrix metalloproteinasesin acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts andepithelial cells following exposure to pro-inflammatory mediators in vitro.Exp Mol Pathol 2004;76:189-95.
  • Wallace S, McEniery CM, Dakham Z, et al. Matrix metalloproteinase-9(MMP-9), MMP-2, and serum elastase activity are associated with systolichypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:372-8.
  • Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors ofmetalloproteinases structure, function, and biochemistry. Circ Res 2003;92:827-39.
  • Vincenti MP, Brinckerhoff CE. Early response genes induced in chondrocytesstimulated with the inflammatory cytokine interleukin-1beta.Arthritis Res 2001;3:381-8.
  • Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle ofregulation of metalloproteinase activity with potential applicability to theentire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A1990;87:5578-82.
  • Takahashi H, Suguro T, Okazima Y, et al. Inflammatory cytokines in theherniated disc of the lumbar spine. Spine 1996;21:218-24.
  • Specchia N, Pagnotta A, Gigante A, et al. Characterization of culturedhuman ligamentum flavum cells in lumbar spine stenosis. J Orthop Res2001;19:294-300.
  • Southgate KM, Davies M, Booth RF, et al. Involvement of extracellularmatrix-degrading metalloproteinases in rabbit aortic smooth-muscle cellproliferation. Biochem J 1992;288(Pt 1):93-9.
  • Snoek-van Beurden P, Von den Hoff JW. Zymographic techniques for theanalysis of matrix metalloproteinases and their inhibitors. Biotechniques2005;38:73-83.
  • Shapiro SD, Fliszar CJ, Broekelmann TJ, et al. Activation of the 92-kDagelatinase by stromelysin and 4-aminophenylmercuric acetate differentialprocessing and stabilization of the carboxyl-terminal domain by tissueinhibitor of metalloproteinases (TIMP). J Biol Chem 1995;270:6351-6.
  • Senior RM, Griffin G, Fliszar C, et al. Human 92-and 72-kilodalton typeIV collagenases are elastases. J Biol Chem 1991;266:7870-5.
  • Schrader P, Grob D, Rahn BA, et al. Histology of the ligamentum flavumin patients with degenerative lumbar spinal stenosis. Eur Spine J 1999;8:323-8.
  • Sato T, Ito A, Ogata Y, et al. Tumor necrosis factor alpha (TNF alpha)induces pro-matrix metalloproteinase 9 production in human uterinecervical fibroblasts but interleukin 1alpha antagonizes the inductive effectof TNF alpha. FEBS lett 1996;392:175-8.
  • Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL-1beta selectivelyinduce expression of 92-kDa gelatinase by human macrophages. JImmunol 1996;157:4159-65.
  • Sairyo K, Biyani A, Goel VK, et al. Lumbar ligamentum flavum hypertrophyis due to accumulation of inflammation-related scar tissue. Spine2007;32:E340-E7.
  • Sairyo K, Biyani A, Goel V, et al. Pathomechanism of ligamentum flavumhypertrophy: a multidisciplinary investigation based on clinical, biomechanical,histologic, and biologic assessments. Spine 2005;30:2649-56.
  • Rosenberg GA, Cunningham LA, Wallace J, et al. Immunohistochemistryof matrix metalloproteinases in reperfusion injury to rat brain: activationof MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brainres 2001;893:104-12.
  • Ramos-DeSimone N, Hahn-Dantona E, Sipley J, et al. Activation ofmatrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1cascade enhances tumor cell invasion. J Biol Chem 1999;274:13066-76.
  • Postacchini F, Gumina S, Cinotti G, et al. Ligamenta flava in lumbar discherniation and spinal stenosis: light and electron microscopic morphology.Spine 1994;19:917-22.
  • Petrinec D, Liao S, Holmes DR, et al. Doxycycline inhibition ofaneurysmal degeneration in an elastase-induced rat model of abdominalaortic aneurysm: preservation of aortic elastin associated with suppressedproduction of 92 kD gelatinase. J Vasc Surg 1996;23:336-46.
  • Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases asmodulators of inflammation and innate immunity. Nat Rev Immunol2004;4:617-29.
  • Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and theregulation of tissue remodelling. Nat Rev Mol Cell Bio 2007;8:221-33.
  • Okada Y, Gonoji Y, Naka K, et al. Matrix metalloproteinase 9 (92-kDagelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells.Purification and activation of the precursor and enzymic properties. J BiolChem 1992;267:21712-9.
  • Ogata Y, Enghild J, Nagase H. Matrix metalloproteinase 3 (stromelysin)activates the precursor for the human matrix metalloproteinase 9. J BiolChem 1992;267:3581-4.
  • Nakatani T, Marui T, Hitora T, et al. Mechanical stretching forcepromotes collagen synthesis by cultured cells from human ligamentumflavum via transforming growth factor-гогС1. J Orthop Res 2002;20:1380-6.
  • Moon HJ, Kim JH, Lee HS, et al. Annulus fibrosus cells interact withneuron-like cells to modulate production of growth factors and cytokinesin symptomatic disc degeneration. Spine 2012;37:2-9.
  • Mohan R, Chintala SK, Jung JC, et al. Matrix metalloproteinase gelatinaseB (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem2002;277:2065-72.
  • Matrisian LM. The matrix-degrading metalloproteinases. BioEssays 1992;14:455-63.
  • Maclay JD, McAllister DA, Rabinovich R, et al. Systemic elastin degradationin chronic obstructive pulmonary disease. Thorax 2012;67:606-12.
  • Longo GM, Xiong W, Greiner TC, et al. Matrix metalloproteinases 2 and9 work in concert to produce aortic aneurysms. J Clin Invest 2002;110:625-32.
  • Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in thepathogenesis of human intervertebral disc degeneration. Arthritis Res Ther2005;7:R732-45.
  • Kuang PP, Goldstein RH. Regulation of elastin gene transcription byinterleukin-1 beta-induced C/EBP beta isoforms. Am J Physiol-Cell Ph2003;285:C1349-55.
  • Kossakowska AE, Edwards DR, Prusinkiewicz C, et al. Interleukin-6regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissueinhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 1999;94:2080-9.
  • Kosaka H, Sairyo K, Biyani A, et al. Pathomechanism of loss ofelasticity and hypertrophy of lumbar ligamentum flavum in elderly patientswith lumbar spinal canal stenosis. Spine 2007;32:2805-11.
  • Kobayashi T, Hattori S, Shinkai H. Matrix metalloproteinases-2 and -9 aresecreted from human fibroblasts. Acta Derm Venereol 2003;83:105-107.
  • Katsuda S, Okada Y, Okada Y, et al. Matrix metalloproteinase-9 (92-kdgelatinase/type IV collagenase equals gelatinase B) can degrade arterialelastin. Am J Pathol 1994;145:1208-18.
  • Kato T, Haro H, Komori H, et al. Sequential dynamics of inflammatorycytokine, angiogenesis inducing factor and matrix degrading enzymesduring spontaneous resorption of the herniated disc. J Orthop Res 2004;22:895-900.
  • Kahari VM, Chen YQ, Bashir MM, et al. Tumor necrosis factor-alphadown-regulates human elastin gene expression. Evidence for the role ofAP-1 in the suppression of promoter activity. J Biol Chem 1992;267:26134-41.
  • Ghajar CM, George SC, Putnam AJ. Matrix metalloproteinase control ofcapillary morphogenesis. Crit Rev Eukaryot Gene Expr 2008;18:251-78.
  • Fridman R, Toth M, Pena D, et al. Activation of progelatinase B(MMP-9) by gelatinase A (MMP-2). Cancer Res 1995;55:2548-55.
  • Dreier R, Grassel S, Fuchs S, et al. Pro-MMP-9 is a specific macrophageproduct and is activated by osteoarthritic chondrocytes via MMP-3 or aMT1-MMP/MMP-13 cascade. Exp Cell Res 2004;297:303-12.
  • Chakraborti S, Mandal M, Das S, et al. Regulation of matrix metalloproteinases:an overview. Mol Cell Biochem 2003;253:269-85.
  • Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frogthat became a prince. Nat Rev Mol Cell Bio 2002;3:207-14.
  • Boyle JR, McDermott E, Crowther M, et al. Doxycycline inhibits elastindegradation and reduces metalloproteinase activity in a model ofaneurysmal disease. J Vasc Surg 1998;27:354-61.
  • Basalyga DM, Simionescu DT, Xiong W, et al. Elastin degradation andcalcification in an abdominal aorta injury model: role of matrixmetalloproteinases. Circulation 2004;110:3480-7.